OOIR: Observatory of International Research

Papers

(The TQCC of Clinical and Translational Allergy is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Is diet partly responsible for differences in COVID-19 death rates between and within countries?	91
Non‐specific lipid‐transfer proteins: Allergen structure and function, cross‐reactivity, sensitization, and epidemiology	70
Worldwide prevalence of rhinitis in adults: A review of definitions and temporal evolution	55
Male sex is strongly associated with IgE-sensitization to airborne but not food allergens: results up to age 24 years from the BAMSE birth cohort	52
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies	51
Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma	38
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)	37
Initiating pollen sensitization – complex source, complex mechanisms	36
IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis	35
Molecular approach to a patient’s tailored diagnosis of the oral allergy syndrome	32
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study	30
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paper	30
Fungal and bacterial microbiome dysbiosis and imbalance of trans-kingdom network in asthma	30
Patients with suspected allergic reactions to COVID‐19 vaccines can be safely revaccinated after diagnostic work‐up	30
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air®	30
Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab	28
The applications of eHealth technologies in the management of asthma and allergic diseases	28
Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work‐up and decision points for vaccination during the COVID‐19 pandemic	26
Genomics of asthma, allergy and chronic rhinosinusitis: novel concepts and relevance in airway mucosa	26
Role of IL‐17 in atopy—A systematic review	25
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy	24
Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances	23
Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study	22
Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs	21
Comorbidities in hereditary angioedema—A population‐based cohort study	21

The role of antifungals in the management of patients with severe asthma	21
Citrullinated histone H3, a marker of extracellular trap formation, is increased in blood of stable asthma patients	20
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model	20
The need for Pan‐European automatic pollen and fungal spore monitoring: A stakeholder workshop position paper	19
Chemokines during anaphylaxis: the importance of CCL2 and CCL2-dependent chemotactic activity for basophils	19
Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis	18
COST Action ‘ImpARAS’: what have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium	18
A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria	18
Secretory protein beta‐lactoglobulin in cattle stable dust may contribute to the allergy‐protective farm effect	18
Current transition management of adolescents and young adults with allergy and asthma: a European survey	17
Psychological needs and support among patients and families undergoing food oral immunotherapy	16
Real‐life effectiveness of biological therapies on symptoms in severe asthma with comorbid CRSwNP	16
DNA methylation biomarkers in asthma and rhinitis: Are we there yet?	16
Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS)	16
Frequency of severe reactions following penicillin drug provocation tests: A Bayesian meta‐analysis	16
Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases—POLLAR symposium under the auspices of Finland’s Presidency of the EU, 2019 and MAC	15
Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis	15
Development of childhood asthma prediction models using machine learning approaches	15
Food protein‐induced enterocolitis syndrome: A large French multicentric experience	14
Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy	14
Viral infections and wheezing–asthma inception in childhood: is there a role for immunomodulation by oral bacterial lysates?	14
Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes	13
En route to personalized medicine: uncovering distinct IgE reactivity pattern to house dust mite components in Brazilian and Austrian allergic patients	13
Direct and indirect costs of allergic and non‐allergic rhinitis to adults in Beijing, China	13
New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines?	13
Eustachian tube dysfunction in patients with house dust mite-allergic rhinitis	13
Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta‐analysis	13
Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey	13
Immunoregulatory effects of Lactococcus lactis‐derived extracellular vesicles in allergic asthma	12
Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications	12
Increasing incidence of anaphylaxis in Hong Kong from 2009 to 2019—discrepancies of anaphylaxis care between adult and paediatric patients	12
EAACI anaphylaxis guidelines: systematic review protocol	12
Leptin favors Th17/Treg cell subsets imbalance associated with allergic asthma severity	12
Epigenome-wide association study identifies DNA methylation markers for asthma remission in whole blood and nasal epithelium	12
The basophil activation test differentiates between patients with wheat‐dependent exercise‐induced anaphylaxis and control subjects using gluten and isolated gluten protein types	12
Anomalous asthma and chronic obstructive pulmonary disease Google Trends patterns during the COVID-19 pandemic	12
Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis	11
Omalizumab for successful chemotherapy desensitisation: What we know so far	11
Environmental and sensitization variations among asthma and/or rhinitis patients between 2008 and 2018 in China	11
The disease burden in patients with respiratory allergies induced by house dust mites: a year-long observational survey in three European countries	11
EAACI Task force Clinical epidemiology of anaphylaxis: experts’ perspective on the use of adrenaline autoinjectors in Europe	11
Large‐scale plasma proteomics can reveal distinct endotypes in chronic obstructive pulmonary disease and severe asthma	11
Gram‐negative microbiota is related to acute exacerbation in children with asthma	11
Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort	11
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities	11
Variation in IgE binding potencies of seven Artemisia species depending on content of major allergens	10
IL‐19 induced by IL‐13/IL‐17A in the nasal epithelium of patients with chronic rhinosinusitis upregulates MMP‐9 expression via ERK/NF‐κB signaling pathway	10
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)	10
Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features	10
Apple allergy: Causes and factors influencing fruits allergenic properties–Review	10

Integration of in vitro allergy test results and ratio analysis for the diagnosis and treatment of allergic patients (INTEGRA)	9
Association of asthma genetic variants with asthma‐associated traits reveals molecular pathways of eosinophilic asthma	9
Unravelling the expression of interleukin-9 in chronic rhinosinusitis: A possible role for Staphylococcus aureus	9
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analys	9
Systematic review of monotherapy with biologicals for children and adults with IgE‐mediated food allergy	9
IgE-binding to vicilin-like antimicrobial peptides is associated with systemic reactions to macadamia nut	9
Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis	9
Predictive significance of Charcot‐Leyden crystal structures for nasal polyp recurrence	9
A meta‐analysis on allergen‐specific immunotherapy using MCT^® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis	9
Mobile health app for monitoring allergic rhinitis and asthma in real life in Lithuanian MASK‐air users	8
Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation – summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children,	8
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air^®approach	8
Protocol of safe vaccination against COVID‐19 in patients with high risk of allergic reactions	8
Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?	8
IgE and high‐affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance	8
Characteristics, mechanism, and management of pain in atopic dermatitis: A literature review	8
Heterogeneous validity of daily data on symptoms of seasonal allergic rhinitis recorded by patients using the e‐diary AllergyMonitor®	8
Birch allergen challenges in allergic conjunctivitis using standard conjunctival allergen challenge and environmental exposure chamber	8
Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria	8
Effects of early‐life exposure to dust mite allergen and endotoxin on the development of asthma and wheezing: The Japan Environment and Children's Study	8
Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis	8
Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response	8
Total IgE in tears accurately reflects the severity and predicts the prognosis of seasonal allergic conjunctivitis	8
Combinations of self‐reported rhinitis, conjunctivitis, and asthma predicts IgE sensitization in more than 25,000 Danes	8
Pru du 1, the Bet v 1‐homologue from almond, is a major allergen in patients with birch pollen associated almond allergy	7
Incidence of anaphylaxis and accidental peanut exposure: A systematic review	7
Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper	7
Predictors of asthma‐related quality of life in a large cohort of asthmatics: A cross‐sectional study in a secondary care center	7
Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports	7
Control of Allergic Rhinitis and Asthma Test: A systematic review of measurement properties and COSMIN analysis	7
The health economic impact of cow's milk allergy in childhood: A retrospective cohort study	7
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model	7
Contact allergens in moisturizers in preventative emollient therapy – A systematic review	7
Cross‐reactivity between tick and wasp venom can contribute to frequent wasp sensitization in patients with the α‐Gal syndrome	7
Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab	7